Posted: October 25, 2019
FACULTY OF PHARMACY AND PHARMACEUTICAL SCIENCES
Team: Arash Panahifar, Morteza Mahmoudi
Patent 9,950,082: Preparation of bone-seeking superparamagnetic iron nanoparticles as contrast agents and methods for using the same.
Doschak and his team developed bone-seeking iron oxide nanoparticles for magnetic resonance imaging (MRI) of bone metabolism. MRI is a powerful diagnostic modality for imaging and assessment of soft tissue and inflammation, but currently can’t be used to detect bone metabolism. Doschak’s new bone-seeking contrast agents open the possibility to use MRI to monitor bone activity and soft tissue health in a single imaging procedure. This technology may serve as a non-ionizing replacement for X-ray and radionuclide diagnostic imaging procedures required to diagnose or monitor bone micro-fracture and for tracking conditions associated with altered bone metabolism, such as arthritis and osteoporosis.
The TEC Edmonton Innovation Awards celebrate the success of University of Alberta researchers. In 2019, awards were presented to ten University of Alberta spin-off companies and nine research teams that received a US patent and have an industry partner.